Chronic Kidney Disease in Cancer Survivors.
Cancer survivorship
Chemotherapy
Immunotherapy
Journal
Advances in chronic kidney disease
ISSN: 1548-5609
Titre abrégé: Adv Chronic Kidney Dis
Pays: United States
ID NLM: 101209214
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
21
06
2021
revised:
12
10
2021
accepted:
25
10
2021
entrez:
22
2
2022
pubmed:
23
2
2022
medline:
22
3
2022
Statut:
ppublish
Résumé
As breakthroughs in cancer care are leading to improved long-term outcomes in a subset of advanced cancers, there is a growing population of long-term cancer survivors that are at risk of long-term complications. In this review, we summarize what is known about chronic kidney disease in cancer survivors, focusing on the following high-risk groups: survivors of childhood cancers, stem cell transplant recipients, patients with renal cell carcinoma, patients exposed to cisplatin and other nephrotoxic chemotherapies, and patients receiving immunotherapy for cancer. As new anticancer therapies are developed, more research is needed to understand the long-term risks of kidney function decline and to devise methods to prevent chronic kidney disease.
Identifiants
pubmed: 35190113
pii: S1548-5595(21)00128-2
doi: 10.1053/j.ackd.2021.10.007
pii:
doi:
Substances chimiques
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
469-476.e1Informations de copyright
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.